Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Sotio Biotech Inc.
Pfizer
Takeda
Ocellaris Pharma, Inc.
Actym Therapeutics, Inc.
NiKang Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Sanofi
Pfizer
NuCana plc
University of Virginia
Telix Pharmaceuticals (Innovations) Pty Limited
Hutchmed
Black Diamond Therapeutics, Inc.
Kymab Limited
Mayo Clinic
Seagen Inc.
Seagen Inc.
Seagen Inc.
Aminex Therapeutics, Inc.
Inhibrx Biosciences, Inc
Rain Oncology Inc
Pfizer
ADC Therapeutics S.A.
University of Florida
Fusion Pharmaceuticals Inc.
pharmaand GmbH
Fate Therapeutics
Fate Therapeutics
Genmab
Incyte Corporation
Gossamer Bio Inc.
Silverback Therapeutics
Incyte Corporation
Seagen Inc.
KitovPharma
AIDS Malignancy Consortium
CureOne
National Institutes of Health Clinical Center (CC)
Cornerstone Pharmaceuticals
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Merck Sharp & Dohme LLC
Mirati Therapeutics Inc.
New Mexico Cancer Research Alliance
National Cancer Institute (NCI)
Auron Healthcare GmbH
National Cancer Institute (NCI)
Massachusetts General Hospital
Cancer Research UK